Definitive Contract W81XWH22C0045
Award Date
9/6/22
Potential Completion Date
1/5/26
Potential Value
$1.2M
Funding Federal Agency
Medical Command
Contracting Federal Agency
Defense Health Agency
Awardee
Altrazeal Life Sciences Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Addison, TX 75001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
Altrazeal Life Sciences Inc., doing business as Uluru, was awarded a $167,448.80 Small Business Innovation Research (SBIR) Phase I purchase order contract from the U.S. Department of the Army Medical Command. The contract is for research and development of "Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire." This work supports the Army's medical research and development efforts. Altrazeal is a small business manufacturer of medical...
This federal contract award is for a Small Business Innovation Research (SBIR) Phase I effort by Altrazeal Life Sciences Inc., doing business as Uluru, to develop an "Innovative Adaptive Drug Delivery System Enhanced Neuroprotection Repair Traumatic Brain Injuries from Penetrating Trauma Open Skull Fractures in Low Resource Envir." The $249,999.96 firm fixed-price contract was awarded by the Defense Health Agency (DHA) on October 7, 2024 and runs through May 6, 2025. The research is...
The Department of the Army Medical Command awarded Kericure Inc.'s Kericure Medical Division a $2.2 million firm fixed price contract under the Small Business Innovation Research Program Phase II solicitation for deployable wound care products. The contract aims to decrease preventable death outcomes by mitigating infection on the battlefield and through long-term care. As a Phase II SBIR award from the Army, the contract builds upon prior research and development efforts to further mature...
This is a U.S. Army SBIR (Small Business Innovation Research) Phase II contract awarded to Silk Technologies, Ltd., a for-profit manufacturer, in the amount of $1,536,825.77. The contract was set aside for small businesses and was awarded by the Department of the Army Medical Command. The contract is for STTR (Small Business Technology Transfer) Phase III research, which typically involves the commercialization of technologies developed under previous SBIR/STTR phases. The work will be...
The Department of the Army Medical Command awarded a $999,812.85 firm fixed price definitive contract to Advanced Life Technologies, LLC of Santa Barbara, California under Topic DHA17-002 of the Department of Defense Small Business Innovation Research Program Phase II solicitation. The contract calls for Advanced Life Technologies to perform research and development of additive manufacturing techniques for biomimetic self-healing composite tissues through May 2022. As a total small business...
The U.S. Department of the Army Medical Command has awarded a $2,195,569.75 definitive contract to Ifyber LLC, a small business located in Ithaca, New York. The contract is for the research and development of "Standard-Issue Antimicrobial Combat Burn Gauze" under Phase II of the Small Business Innovation Research (SBIR) program. The award has a total small business set-aside designation and will support work over a four-year period through March 2025. In addition to this contract,...
<p>This is a $1,432,104.50 Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Medical Command (MEDCOM) to Silk Technologies, Ltd., a for-profit manufacturer located in Maple Grove, Minnesota. The contract was awarded on June 29, 2016 and has a final completion date of June 12, 2019. It is a fixed-price level of effort contract. The contract is designated as a total small business set-aside. No major subcontractors are mentioned.</p>
This is a firm fixed-price purchase order awarded to Zymeron Corporation, a minority-owned small business, under the Department of the Army Medical Command's Small Business Innovation Research (SBIR) program. The $250,000.00 Phase I contract is for the research and development of a "Novel Aerosol Therapy for Immediate and Sustained ARDS Management". Zymeron, a biotechnology company focused on areas like drug delivery systems, will perform this medical research at its facilities in...
This is a $149,491.44 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Xequel Bio, Inc., a for-profit biomedical research and development company. The contract supports research aligned with Army medical priorities, with a focus on developing innovative solutions for battlefield trauma, medical countermeasures, and regenerative medicine. Xequel Bio has received multiple federal contracts and grants for its work in these areas,...
The Department of the Army Medical Command awarded Keranetics Inc., doing business as Keranetics, a $699,139.77 firm fixed price contract to support research and development efforts under Phase II of the Small Business Innovation Research program. The contract aims to advance Keranetics' KeraStat(R) gel technology to prevent scar contracture after burn injuries, as proposed in their submission titled "KeraStat(R) Gel to Prevent Scar Contracture After Burn Injuries." The prime...